Role of 2-Deoxy-D-Glucose (2-DG) in COVID-19 disease: A potential game-changer.
Where this comes from
- Record sourced from PubMed, PMID 34934645.
- Also identified by DOI 10.4103/jfmpc.jfmpc_1338_21 and PMC identifier 8653447.
- Licence recorded as CC BY-NC-SA.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Virus infections can cause tissue damage in many ways. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a cause of the current COVID-19 pandemic, has been extensively studied so far to investigate its pathophysiology and evaluate its impact on the metabolic system of human cells. This has given a lead to study the role of 2-deoxy-D-glucose (2DG) against COVID-19 disease. We hereby would like to briefly discuss the concept and rationale behind the use of 2DG COVID-19.